drugset
Drugs / Subvirion inactivated influenza A/H9N2 (G9 variant) vaccine
last change Jan 2009 re-read 3 minutes ago

Subvirion inactivated influenza A/H9N2 (G9 variant) vaccine

Vaccine

Developed for
influenza
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID)

Trials 1

today NCT00617331 · Ph 2
20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00617331 Feb → Aug 2008 influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Subvirion inactivated influenza A/H9N2 (G9 variant) vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00617331 ↗
Modality Vaccine “Subvirion inactivated influenza A/H9N2 (G9 variant) vaccine” NCT00617331 ↗
Route Intramuscular “Inactivated subvirion influenza A/chicken/Hong Kong/G9/97 (H9N2) vaccine administered via intramuscular (IM) injection” NCT00617331 ↗